News Releases

Clement Tagoe, M.D., Ph.D., Named Chief of Rheumatology
Einstein Students Learn Match Results Amid COVID-19 Crisis
Experimental Drug May Prevent Chemotherapy Drug from Damaging the Heart

Facts & Stats

Published Papers
NIH Research Funding
Students
Full-time Faculty
Global Initiatives
Clinical and Research Centers
Alumni

Expert List for Media

Chaim Putterman

Chaim Putterman, M.D.

Area(s) of expertise: ArthritisLupusAutoimmune diseases

Dr. Putterman is a clinical rheumatologist who treats arthritis and related musculoskeletal and autoimmune diseases. Dr. Putterman specializes in lupus, an incurable autoimmune disease affecting 1.5 million Americans that causes inflammation, pain and… Learn more

Einstein in the News


USA Today
'It’s time to save people': Synagogue members who had coronavirus donate blood to help others

Liise-anne Pirofski, M.D., comments on the use of plasma from people who have recovered from COVID-19 to potentially prevent and treat the disease. Dr. Pirofski is chief of infectious diseases at Einstein and Montefiore Health System. 

Additional coverage of Dr. Pirofski on COVID-19 includes: NatureThe AtlanticWall Street Journal (subscription required), Associated PressNPRLA TimesNBC NewsCBS News

More coverage on Dr. Pirofski

Wired
Blood from COVID-19 Survivors Might Point the Way to a Cure

Kartik Chandran, Ph.D., explains the process of developing monoclonal antibodies, synthetic antibodies that target a specific infection, and the race to create them to treat people with COVID-19. Dr. Chandran is professor of microbiology & immunology.

More coverage on Dr. Chandran

Bloomberg
Trump Pushes Malaria Drug for COVID19 But Evidence is Lacking

David Goldman, M.D., is designing a clinical trial to evaluate hydroxychloroquine, which has been used in previous viral outbreaks, as a preventive treatment for COVID-19 in elderly patients living in nursing homes. Dr. Goldman is associate professor of pediatrics and of microbiology & immunology and a pediatric infectious disease specialist at Children's Hospital at Montefiore.

Multimedia

When a Drug Becomes a Child’s Last Hope

Einstein scientist Vern Schramm, Ph.D., never imagined that his basic research into enzymes would intersect with a 2-year-old girl dying from an incurable form of blood cancer. He and that girl (Katie Lambertson, now a teenager) and her parents share their stories.

Watch more videos

The Doctor's Tablet Blog